A modified algorithm with lipoprotein(a) added for diagnosis of familial hypercholesterolemia

Simplified Canadian Definition for Familial Hypercholesterolemia

(2018) Isabelle Ruel et al.   CANADIAN JOURNAL OF CARDIOLOGY

Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study

(2018) Manuela Casula et al.   ATHEROSCLEROSIS

Clinical Genetic Testing for Familial Hypercholesterolemia

(2018) Amy C. Sturm et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Plasma lipoprotein(a) levels in patients with homozygous autosomal dominant hypercholesterolemia

(2017) Barbara Sjouke et al.   Journal of Clinical Lipidology

The roles of apo(a) size, phenotype, and dominance pattern in PCSK9-inhibition-induced reduction in Lp(a) with alirocumab

(2017) Byambaa Enkhmaa et al.   JOURNAL OF LIPID RESEARCH

Novel and traditional lipid-related biomarkers and their combinations in predicting coronary severity

(2017) Sha Li et al.   Scientific Reports

Familial Hypercholesterolemia Phenotype in Chinese Patients Undergoing Coronary AngiographyHighlights

(2016) Jian-Jun Li et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Homozygous Familial Hypercholesterolemia in SpainCLINICAL PERSPECTIVE

(2016) Rosa M. Sánchez-Hernández et al.   Circulation-Cardiovascular Genetics

Familial Hypercholesterolemia in Asian Populations

(2016) Mengge Zhou et al.   Journal of Atherosclerosis and Thrombosis

Tendon xanthomas: Not always familial hypercholesterolemia

(2016) Charlotte Koopal et al.   Journal of Clinical Lipidology

The re-emergence of lipoprotein(a) in a broader clinical arena

(2016) Sotirios Tsimikas   PROGRESS IN CARDIOVASCULAR DISEASES

Homozygous Familial Hypercholesterolemia in SpainCLINICAL PERSPECTIVE

(2016) Rosa M. Sánchez-Hernández et al.   Circulation-Cardiovascular Genetics

High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study

(2016) Anne Langsted et al.   Lancet Diabetes & Endocrinology

Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)

(2015) Stephen F. Weng et al.   ATHEROSCLEROSIS

Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease – A study supported by the Korean Society of Lipidology and Atherosclerosis

(2015) Dong Geum Shin et al.   ATHEROSCLEROSIS

The Agenda for Familial Hypercholesterolemia

(2015) Samuel S. Gidding et al.   CIRCULATION

‘LDL-C’ = LDL-C + Lp(a)-C

(2015) Calvin Yeang et al.   CURRENT OPINION IN LIPIDOLOGY

Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia

(2015) Dick C. Chan et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Sitosterolemia: Diagnosis, Investigation, and Management

(2014) Joan Carles Escolà-Gil et al.   Current Atherosclerosis Reports

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

(2014) M. Cuchel et al.   EUROPEAN HEART JOURNAL

Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management

(2014) Shuke Nie et al.   Orphanet Journal of Rare Diseases

Diagnosis and treatment of familial hypercholesterolaemia

(2013) G. Kees Hovingh et al.   EUROPEAN HEART JOURNAL

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

(2013) B. G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Guidelines for the Management of Familial Hypercholesterolemia

(2012) Mariko Harada-Shiba et al.   Journal of Atherosclerosis and Thrombosis

Lipoprotein(a) metabolism: Potential sites for therapeutic targets

(2012) Jane Hoover-Plow et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia

(2011) Marit S. Nenseter et al.   ATHEROSCLEROSIS

Lipoprotein(a) as a cardiovascular risk factor: current status

(2010) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL